Berkshire Hathaway Inc. (BRK.B) vs Eli Lilly and Company (LLY)
A side-by-side comparison of Berkshire Hathaway Inc. and Eli Lilly and Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: BRK.B is classified in Financial Services; LLY is classified in Healthcare. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
BRK.B
Berkshire Hathaway Inc.
$512.37Financial ServicesDelayed quote: Jul 28, 2026, 4:00 PM EDT
LLY
Eli Lilly and Company
$1,222.61HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — BRK.B vs LLY
growth of $100 · dividends reinvested · last 30yBRK.B +2314.3%LLY +8631.2%LLY compounded faster
BRK.B LLY
BRK.B vs LLY: by the numbers
- •LLY is the larger company ($1.15T vs $1.11T market cap).
- •BRK.B trades at the lower trailing earnings multiple (14.80 vs 42.54 P/E), one valuation lens rather than an overall verdict.
- •LLY converts more revenue to profit (34.98% vs 19.31% net margin).
- •LLY grew revenue faster over the past five years (23.17% vs 8.57% CAGR).
- •LLY pays a dividend (0.54% yield), while BRK.B has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BRK.B | LLY |
|---|---|---|
| P/E ratio | 14.80 | 42.54 |
| Forward P/E | 23.89 | 34.10 |
| P/S ratio | 2.86 | 14.85 |
| P/B ratio | 1.47 | 34.39 |
| PEG ratio | 1.26 | 0.49 |
| EV / EBITDA | N/A | 31.98 |
| FCF yield | N/A | 1.27% |
Profitability
| Metric | BRK.B | LLY |
|---|---|---|
| Gross margin | 25.14% | 83.51% |
| Operating margin | 16.06% | 45.87% |
| Net margin | 19.31% | 34.98% |
| ROE | 9.97% | 81.01% |
| ROIC | 4.12% | 30.20% |
Dividends
| Metric | BRK.B | LLY |
|---|---|---|
| Dividend yield | N/A | 0.54% |
| Payout ratio | N/A | 28.09% |
Growth (annualized)
| Metric | BRK.B | LLY |
|---|---|---|
| Revenue CAGR (5Y) | 8.57% | 23.17% |
| EPS CAGR (5Y) | 11.79% | 28.88% |
| FCF CAGR (5Y) | N/A | 19.54% |
| Total return CAGR (5Y) | 12.93% | 38.81% |
Frequently asked
- Which has the lower trailing P/E, BRK.B or LLY?
- BRK.B has the lower trailing P/E: BRK.B trades at 14.80 and LLY at 42.54. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, BRK.B or LLY?
- Over the past five years, LLY grew revenue faster — BRK.B at a 8.57% CAGR versus LLY at 23.17%.
- Does BRK.B or LLY pay a bigger dividend?
- LLY pays a dividend (0.54% yield), while BRK.B has no payments in the available dividend history.
- Is BRK.B or LLY more profitable?
- LLY runs the higher net margin — BRK.B at 19.31% versus LLY at 34.98%.
- How have BRK.B and LLY total returns compared?
- Over the past 10 years, BRK.B delivered 13.47% and LLY delivered 32.66% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Berkshire Hathaway P/E ratioEli Lilly and P/E ratioBerkshire Hathaway dividend yieldEli Lilly and dividend yieldBerkshire Hathaway ROEEli Lilly and ROEBerkshire Hathaway operating marginEli Lilly and operating marginBerkshire Hathaway revenue growthEli Lilly and revenue growthBerkshire Hathaway free cash flowEli Lilly and free cash flow
Berkshire Hathaway & Eli Lilly and appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.